about
Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients.ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer.Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield.Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.Protective Effect of Aspirin Against Oligomeric Aβ42 Induced Mitochondrial Alterations and Neurotoxicity in Differentiated EC P19 Neuronal Cells.The translocation t(2;11)(p21;q23) without MLL gene rearrangement--a possible marker of good prognosis in myelodysplastic syndrome patients.Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.Polychlorinated biphenyl 153 in lipid medium modulates differentiation of human adipocytes.[Tumour-stroma interactions in urothelial cancer].Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analysesIndependent coexistence of clones with 13q14 deletion at reciprocal translocation breakpoint and 13q14 interstitial deletion in chronic lymphocytic leukemiaAllogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatmentPrecise determination of primary cytogenetic abnormalities provides added value for stratification of chronic lymphocytic leukemia patientsCirculating and circular RNAs and the need for rationalization and synthesis of the research spiralKRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanesFunctionally Significant Features in the 5' Untranslated Region of the ABCA1 Gene and Their Comparison in Vertebrates
P50
Q38619022-EE61C974-187C-4E05-8C15-68BDBC6C44CBQ38806608-7A27B620-1FFA-423A-85E7-45F9B0326CD8Q41578847-E82E351C-607C-4F9C-9D6B-4867BD430EE7Q45249684-32F67BA2-3927-47A6-B28A-09B4B0F798A7Q46269535-12AAB196-9D72-460A-8B8E-51CEB95DC942Q46422751-20D7309D-A7AD-42F0-8CD1-969FC2173911Q47769358-5AE325ED-AA0E-4FC5-A35F-F2B592443FFAQ49277521-5FE780A5-2257-4169-8EFD-89E518C6DC0AQ51061008-9DD7754A-18E1-4136-88CB-CCDD2B11AA3BQ53536050-00AED797-9F7E-410D-A3CD-DD2FE9E47C46Q64262887-90034381-B41C-4707-82C5-93671F81FE91Q83489667-3A3E9A7B-D7CB-4118-8AB1-D47BDD37DF9AQ86483058-FAF213B6-321E-4217-9CB3-91015384B1EEQ90220376-F611781E-53BB-4AEC-9B00-4DBD2D5CC3F7Q92186933-A328923F-13C0-4CBB-95F9-B63E97B1BB00Q92378118-A8B89B7E-5DA0-448C-BA5C-6114ED537C9BQ92989971-A3FC1836-91B8-48F6-A712-2796AF739143
P50
description
researcher ORCID ID = 0000-0002-2124-7219
@en
wetenschapper
@nl
name
Pavel Dvorak
@ast
Pavel Dvorak
@en
Pavel Dvorak
@es
Pavel Dvorak
@nl
type
label
Pavel Dvorak
@ast
Pavel Dvorak
@en
Pavel Dvorak
@es
Pavel Dvorak
@nl
prefLabel
Pavel Dvorak
@ast
Pavel Dvorak
@en
Pavel Dvorak
@es
Pavel Dvorak
@nl
P1153
56742878200
P21
P31
P496
0000-0002-2124-7219